Skip to content
Join our Newsletter

Technology

From keeping cool to prioritizing people, how B.C. businesses are supporting vaccine rollout

From keeping cool to prioritizing people, how B.C. businesses are supporting vaccine rollout

B.C. companies are stepping up to assist with the rollout of the vaccine
AbCellera’s market value hits US$15.7b after first day of trading

AbCellera’s market value hits US$15.7b after first day of trading

Vancouver biotech known for its work on a COVID-19 treatment
Beware – Santa could bring home cybersecurity risks

Beware – Santa could bring home cybersecurity risks

Proliferation of home high-tech gadgets could expose personal data to crooks
AbCellera IPO: Shares surge more than 250% upon debut (UPDATED)

AbCellera IPO: Shares surge more than 250% upon debut (UPDATED)

Trading held at the opening of markets
AbCellera boosts IPO target second time in a week, seeks to raise US$483m

AbCellera boosts IPO target second time in a week, seeks to raise US$483m

The B.C. biotech firm instrumental in the development of a COVID-19 treatment has boosted its ambitions for an initial public offering for the second time in a week. AbCellera Biologics Inc.
Boast.AI raises $30m as B.C. tech firm hones in on R&D tax credits for others

Boast.AI raises $30m as B.C. tech firm hones in on R&D tax credits for others

Vancouver company plans to boost its headcount following close of Series A funding round
B.C. biotech in the spotlight after Health Canada approves Pfizer-BioNTech vaccine

B.C. biotech in the spotlight after Health Canada approves Pfizer-BioNTech vaccine

Vancouver-based Acuitas Therapeutics played key role in vaccine's development
Parallel Domain eyes Vancouver expansion in pursuit of computer vision tech

Parallel Domain eyes Vancouver expansion in pursuit of computer vision tech

Expansion plans for tech company’s Vancouver office come amid US$11m raise
‘Their brains have changed’: How technology will transform life in 2021

‘Their brains have changed’: How technology will transform life in 2021

Annual Deloitte report reveals top tech, media and telecom predictions for the new year
Vancouver’s AbCellera now aiming to raise as much as US$450m in IPO

Vancouver’s AbCellera now aiming to raise as much as US$450m in IPO

Biotech had originally been targeting a US$200m raise